Key result
Hepatitis C is linked to a ~34% depression prevalence, exceeding rates in IBS and IBD.
Why the study?
The relative psychological burden of IBD, IBS, and HCV has never been compared contemporaneously at one institution to guide allocation of clinical psychological resources.
Cross-Sectional (n=139)
No
Patients with chronic gastrointestinal diseases, particularly HCV, have significant impairment in quality of life and high rates of anxiety and depression, warranting regular psychological monitoring.
Answers are grounded in this paper and cite their sources.
Offers contemporaneous local data on relative psychological burdens; leaves open generalizability and need for prospective validation.
BACKGROUND: In independent studies, IBD, IBS and HCV have each been associated with a substantially increased risk of psychological problems such as depression and anxiety and impairment of quality of life compared to the general healthy population. However, the relative psychological burden for each of these diagnoses is unknown as it has never been compared contemporaneously at one institution. Current local data are therefore needed to enable an evidence-based allocation of limited clinical psychological resources. METHODS: Overall, 139 outpatients (64 IBD, 41 HCV, and 34 IBS) were enrolled in this cross-sectional study. The HADS, SCL90, SF-12 and appropriate disease-specific activity measures were administered. Differences between groups were assesed with ANOVA, the Chi-Square test and the independent samples t-test (two-tailed). RESULTS: Each of the three groups had significantly lower quality of life than the general population (p < 0.05). Overall, a total of 58 (42%) participants met HADS screening criteria for anxiety and 26 (19%) participants for depression. The HCV group had a significantly higher prevalence of depression than either of the other groups (HCV = 34%, IBS = 15% and IBD = 11%, p = 0.009). In the SCL90, the three disease groups differed on 7 out of 12 subscales. On each of these subscales, the HCV group were most severely affected and differed most from the general population. CONCLUSION: Patients with these common chronic gastrointestinal diseases have significant impairment of quality of life. Anxiety is a greater problem than depression, although patients with HCV in particular, should be regularly monitored and treated for co-morbid depression. Evaluation of specific psychological interventions targeting anxiety is warranted.
No takes yet. Share an insight, caveat, or question.
Mikocka‐Walus et al. (2008) conducted a cross-sectional in Inflammatory Bowel Disease (IBD), Irritable Bowel Syndrome (IBS), and Hepatitis C (HCV) (n=139). Hepatitis C (HCV) vs. Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS) was evaluated on Prevalence of depression (HADS score > 7) (p=0.009). Patients with hepatitis C had a higher prevalence of depression compared to those with irritable bowel syndrome and inflammatory bowel disease.
Synapse has enriched 10 related papers. Consider them for comparative context: